載入...
Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
AZD0530, an orally available Src inhibitor, demonstrated potent antimigratory and anti‐invasive effects in vitro, and inhibited metastasis in a murine model of bladder cancer. Antiproliferative activity of AZD0530 in vitro varied between cell lines (IC50 0.2 –>10μM). AZD0530 inhibited tumor growt...
Na minha lista:
發表在: | Mol Oncol |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
John Wiley and Sons Inc.
2009
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5527863/ https://ncbi.nlm.nih.gov/pubmed/19393585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2009.01.002 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|